Source: Alvimedica

Fluydo™ NC - CE Mark Approval

Alvimedica today announced the CE mark approval of Fluydo™ NC, its new PTCA NON-COMPLIANT Balloon Catheter

ALVIMEDICA, Istanbul, 29-03-2021 —Alvimedica today has announced the CE mark approval of Fluydo™ NC, its new PTCA Non-Compliant Balloon Catheter.

Fluydo™ NC is a new Non-Compliant Balloon designed to cross and effectively dilate the hardest lesions located into the most difficult and challenging coronary lesions. Alvimedica has developed the Fluydo™ NC Balloon to meet the physicians’ need of having available a coronary high-pressure balloon catheter able to merge non-compliant dilatation features with superb crossability. In fact, Fluydo™ NC embeds in one single device an extremely high Rated Burst Pressure (up to 22 atm) with a very low crossing profile and excellent crossability performance.

Fluydo™ NC is a real versatile NC balloon catheter available in a wide size matrix: with diameters ranging from 1.75mm to 5.00mm and lengths from 6 to 30mm, it can be used for pre-dilatations and for post-dilatations of tight and highly calcified lesions like those of diabetic patients.

Due to the implementation of all the state-of-the-art technologies in the manufacturing of the balloon components, Fluydo™ NC is 6Fr Guiding Catheter compatible for kissing balloon procedures with the whole range of available sizes (any two Fluydo™ NC with at least one with diameter up to 3.25mm are 6Fr KB compatible).

Fluydo™ NC is manufactured by CID S.p.A. member of Alvimedica group and represents one of the most innovative technology in the Non-Compliant Coronary Balloon catheter scenario to date, ensuring the highest efficacy and safety profile for the patients.

Leyla Alaton, President of Alvimedica, has commented: “We believe that Fluydo™ NC will help physicians making their complex PCI procedures successful, especially those requiring the most advanced devices. Here in Alvimedica we are committed to developing devices that further advance the treatment of patients in interventional cardiology. The Alvimedica never ending effort to offer the most updated tools is also proven by the recent introduction of the improved version of our work-horse Semi-Compliant PTCA balloon catheter Invader™ PTCA.”

About Alvimedica

Alvimedica is a young, innovative company devoted to developing minimally-invasive technologies for medical professionals looking for the next level of innovation in the operating room. We firmly believe that working closely with physicians is the best way to improve our product solutions and services; our ‘co-creation approach’ results in an innovative endovascular product portfolio and in a range of products aimed at meeting needs so far unmet in interventional cardiology.

Alvimedica invites medical professionals to join its ambitions in creating best medical devices for people around the globe.

RELATED CONTENT